Bundle Deals

Shop Top Sellers

ENDS SOON

Shop Now
00
:
00
:
00
:
00
Days
Hours
Mins
Secs
  • Product label: ADD 60 TO ACTIVATE OFFER
  • Product label: BUY 40 GET 20 FREE
Ezetimibe   -Bt Ezetimibe   -Bt
Wholesaler Options
  • Product label: ADD 10 TO ACTIVATE OFFER
  • Product label: BUY 5 GET 5 FREE
Varenicline Varenicline
Wholesaler Options
  • Product label: Add 192+ TO ACTIVATE OFFER
  • Product label: BUY 144 GET 48 FREE
Postinor-1 1.5mg Levonorgestrel x 1 tab Postinor-1 1.5mg Levonorgestrel x 1 tab
Wholesaler
  • Product label: ADD 60 TO ACTIVATE OFFER
  • Product label: BUY 40 GET 20 FREE
Ezetimibe Ezetimibe
Wholesaler Options
  • Product label: ADD 10 TO ACTIVATE OFFER
  • Product label: BUY 5 GET 5 FREE
Varenicline 1mg x 56 tabs bt Varenicline 1mg x 56 tabs bt
Wholesaler
Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Rheumatoid Arthritis,Yuflyma is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. This includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate.
Yuflyma can be used alone or in combination with methotrexate.,Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Yuflyma in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,Enthesitis-Related Arthritis,Yuflyma is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,Psoriatic Arthritis,Yuflyma is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous DMARDs has been inadequate.,Ankylosing Spondylitis,Yuflyma is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
Crohn's Disease in Adults and Children (6 years and older),Yuflyma is indicated for the treatment of moderate to severe Crohn's disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients;,· who have had an inadequate response to conventional therapies or,,· who have lost response to or are intolerant to infliximab,Ulcerative colitis,Yuflyma is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. Patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time. (see 5.1 PHARMACODYNAMIC PROPERTIES - CLINICAL TRIALS).,Psoriasis in Adults and Children,Yuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,Yuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,Hidradenitis Suppurativa in Adults and Adolescents (from 12 years of age),Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,Uveitis,Yuflyma is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Generic Name: Adalimumab

Strength:40mg/0.4ml

Dosage:

Shelflife Months: 36

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: Adalimumab 40mg

More info
X
Indication:

Hypertension
PHARMACOR AMLODIPINE is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of PHARMACOR AMLODIPINE, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.
Angina
PHARMACOR AMLODIPINE is indicated for the first line treatment of chronic stable angina. PHARMACOR AMLODIPINE may be used alone, as monotherapy or in combination with other antianginal drugs.

Generic Name: Amlodipine

Strength:5mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off-white, octagonal, flat faced, bevelled edged scored tablet debossed with "210" and "5" on one side and plain on other side

Segment :B

Innovator:Norvasc ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: amlodipine besilate 6.93mg
Equivalent: amlodipine 5mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02327-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02330-1

More info
X
Indication:

Atorvastatin is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.
Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.
Atorvastatin is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see section 5.1, Pharmacodynamic properties, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke.
These effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Generic Name: Atorvastatin

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White elliptical shaped, film coated tablets, debossed with "10" on one side and "ATS" on other side

Segment :B

Innovator:Lipitor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: atorvastatin calcium trihydrate 10.845mg
Equivalent: atorvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02356-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02369-1

More info
X
Indication:


Cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: Acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis.
Acute exacerbations of chronic bronchitis, or acute bronchitis.
Skin and skin structure infections for example, furunculosis, pyoderma and impetigo.
Acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Generic Name: Cefuroxime axetil

Strength:250mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 14

Tablet Description:Blue color capsule shaped biconvex film coated tablets with '204' debossed on one side and plain on the other side

Segment :A

Innovator:Pharmacor Cefuroxime®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cefuroxime axetil 300.715mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-01527-1&d=20241003172310101

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-01526-1&d=20241003172310101

More info
X
Indication:


Generic Name: Cephalexin

Strength:500mg

Dosage:Caps

Shelflife Months: 36

Pack Size: 20

Tablet Description:

Segment :B

Innovator:Keflex®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:

Active Ingredients:

More info
X
Indication:

Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism in patients with end stage renal disease, receiving dialysis. Cinacalcet should be used as adjunctive therapy. ,Cinacalcet is indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma. ,Cinacalcet may be used to treat the biochemical manifestations of primary hyperparathyroidism in patients for whom parathyroidectomy is not a treatment option.

Generic Name: Cinacalcet

Strength:30mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 28

Tablet Description:Light green colored, oval shaped, film coated tablets debossed with 'A33' on one side
and '30' on other side

Segment :A

Innovator:Sensipar®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cinacalcet hydrochloride 66mg Equivalent: cinacalcet 60mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01248-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01250-1

More info
X
Indication:

Clobazam is indicated in Adults -Short term use (up to one month) for the symptomatic management of acute anxiety and sleep disturbances associated with anxiety and in Children (4 years of age and over) - As adjunctive therapy in patients with partial refractory and Lennox-Gastaut epilepsy types who are not adequately stabilized with their current anticonvulsant therapy.

Generic Name: Clobazam

Strength:10mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off white oval shaped uncoated tablets with a functional score on one side and "C" and "10" debossed on other side

Segment :B

Innovator:Frisium®

PBSListed:No

RPBSlisted:No

Schedule: S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: clobazam 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01888-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01886-1

More info
X
Indication:

Relief of pain in acute gout. Colchicine should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient. Colchicine is not an analgesic and does not provide relief from other types of pain.

Generic Name: Colchicine

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 31

Pack Size: 30

Tablet Description:Round, off white coloured biconvex, uncoated tablets embossed “C5” on one upper side and plain on the bottom face

Segment :A

Innovator:Colgout®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: colchicine 500 microgram

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01410-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01413-1

More info
X
Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength:110mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator:Pradaxa ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02037-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02036-1

More info
X
Indication:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. Deferasirox is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective.,Deferasirox is also indicated for the treatment of chronic iron overload in patients with nontransfusion-dependent thalassemia syndromes aged 10 years and older.

Generic Name: Deferasirox

Strength:90mg

Dosage:FC Tab

Shelflife Months: 36

Pack Size: 30

Tablet Description:Light blue colour, film coated oval shaped biconvex tablets, debossed with 'DFX' on the one side and '90' on other side

Segment :B

Innovator:Jadenu®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: deferasirox 90mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01406-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01408-1

More info
X
Indication:


Generic Name: DMF

Strength:120g

Dosage:Caps

Shelflife Months: 30

Pack Size: 14

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:

Active Ingredients:

More info
X
Indication:

DULOXETINE is indicated for the treatment of major depressive disorder (MDD).,DULOXETINE is indicated for the treatment of diabetic peripheral neuropathic pain (DPNP).,DULOXETINE is indicated for the treatment of generalised anxiety disorder (GAD)

Generic Name: Duloxetine

Strength:30mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 28

Tablet Description:Opaque blue colour cap and opaque white colour body, imprinted “Dulox” on cap with white ink and “30 mg” on body with black ink

Segment :B

Innovator:Cymbalta®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: duloxetine hydrochloride 33.66mg

More info
X
Indication:

Everolimus is indicated for the prophylaxis of organ rejection in adult patients at mild to moderate immunological risk receiving an allogeneic renal or cardiac transplant and in adult patients receiving an allogeneic hepatic transplant (see section 4.4 Special warnings and precautions for use).

Generic Name: Everolimus

Strength:0.25mg

Dosage:Tab

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to off white, round shaped tablets debossed with "EVR" on one side and "25" on other side

Segment :A

Innovator:Certican®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: everolimus 0.25mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01468-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01469-1

More info
X
Indication:

Adults (≥18 years),Prevention of Cardiovascular Disease,Ezetimibe and Simvastatin Tablets is indicated in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) taking their maximum tolerated dose of simvastatin and in need of additional lowering of LDL-C in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy.,Primary Hypercholesterolaemia,Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).,Children and Adolescents 10-17 years,(pubertal status: boys Tanner Stage II and above and girls who are at least one year post-menarche),Heterozygous Familial Hypercholesterolaemia (HeFH),Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in adolescent patients (10-17 years old) with heterozygous familial hypercholesterolaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in adolescent patients (10-17 years old) with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe ; simvastatin

Strength:10mg;10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, capsule shaped tablets debossed with "A029" on one side and plain on other side

Segment :B

Innovator:Vytorin®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg simvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01201-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01203-1

More info
X
Indication:

Adults (≥18 years),Prevention of Cardiovascular Disease,Ezetimibe and Simvastatin Tablets is indicated in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) taking their maximum tolerated dose of simvastatin and in need of additional lowering of LDL-C in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy.,Primary Hypercholesterolaemia,Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).,Children and Adolescents 10-17 years,(pubertal status: boys Tanner Stage II and above and girls who are at least one year post-menarche),Heterozygous Familial Hypercholesterolaemia (HeFH),Ezetimibe and Simvastatin Tablets is indicated as adjunctive therapy to diet in adolescent patients (10-17 years old) with heterozygous familial hypercholesterolaemia where use of a combination product is appropriate:,· Patients not appropriately controlled with a statin or ezetimibe alone.,· Patients already treated with a statin and ezetimibe.,Homozygous Familial Hypercholesterolaemia (HoFH),Ezetimibe and Simvastatin Tablets is indicated in adolescent patients (10-17 years old) with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe ; simvastatin

Strength:10mg;10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, capsule shaped tablets debossed with "A029" on one side and plain on other side

Segment :B

Innovator:Vytorin®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg simvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-PI-01201-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01203-1

More info
X
Indication:

Primary HypercholesterolaemiaPHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,· not appropriately controlled with rosuvastatin or ezetimibe alone; or,· already treated with rosuvastatin and ezetimibe,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe; Rosuvastatin

Strength:

Dosage:

Shelflife Months:

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-01230-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-01229-1

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Maintain/support bone health
Aids/assists healthy bone development/growth/building
Maintain/support bone mass/density/integrity
Maintain/support bone strength
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate

Generic Name: Cal-Care

Strength:600mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:Tablet, film coated

Segment :B

Innovator:Caltrate®

PBSListed:No

RPBSlisted:Yes

Schedule:UNS

Storage Conditions:

Active Ingredients: calcium carbonate 1.5g

More info
X
Indication:

Topical treatment of fungal skin infections such as tinea or ringworm (eg. tinea pedis, tinea corporis or tinea cruris); Pityriasis versicolor; and candidal,infections (eg. external genital thrush, thrush-infected nappy rash).

Generic Name: Clotrimazole

Strength:0.01

Dosage:Tube

Shelflife Months: 36

Pack Size: 1

Tablet Description:White, smooth semi-solid cream

Segment :B

Innovator:Canesten Cream®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: clotrimazole 1%w/w

More info
X
Indication:

For the treatment of patients with known cardiovascular or cerebrovascular disease as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)

Generic Name: Aspirin

Strength:100mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 168

Tablet Description:Orange coloured circular, biconvex coated tablet having Heart shape embossed on one side and plain on other side

Segment :B

Innovator:Cartia®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: aspirin 100.008mg

More info
X
Indication:

Pharmacor Sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months:

Pack Size:

Tablet Description:Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: sumatriptan succinate 69.99mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01148-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01298-1

X
Indication:

Emergency contraception within 72 hours of unprotected intercourse.

Generic Name: Postinor

Strength:1.5mg

Dosage:Tab

Shelflife Months: 36

Pack Size: 1

Tablet Description:Almost white, flat, rimmed tablet with an impressed mark of "GOO" on one side

Segment :A

Innovator:Postinor®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: levonorgestrel 1.5mg

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.15mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.15mg

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.3mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.3mg

More info
X
Indication:

Temporary relief of acute (short term) pain and / or inflammation associated with:,headache, migraine headache, tension headache, sinus pain, toothache, dental,procedures, backache, muscular aches and pains, period pain, sore throat, tennis,elbow, rheumatic pain and arthritis, and the aches and pains associated with colds and flu.

Generic Name: Fenmol

Strength:500mg;200mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 12

Tablet Description:White to off white coloured, capsule shaped, biconvex, film coated

Segment :B

Innovator:Nuromol ®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ibuprofen 200mg & paracetamol 500mg

More info
X
Indication:

Provides relief from nasal congestion due to colds, influenza, allergies and sinusitis

Generic Name: Decongestant Nasal

Strength:500mcg/mL

Dosage:Spray

Shelflife Months: 30

Pack Size: 1

Tablet Description:A clear colourless liquid

Segment :B

Innovator:Drixine®

PBSListed:No

RPBSlisted:Yes

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: oxymetazoline hydrochloride 0.5 mg/ml

More info
X
Indication:

The symptomatic short term treatment of seasonal allergic conjunctivitis in adults and children 3 years or older.

Generic Name: Ketotifen

Strength:5mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:A clear, colorless solution

Segment :A

Innovator:Zaditen®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ketotifen fumarate 345 microgram/ml
Equivalent: ketotifen 250 microgram/ml

X
Indication:

Helps enhance/promote bone health
Aids/assists healthy bone development/growth/building
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life
Helps reduce occurrence of muscle cramp
Maintain/support muscle health during the day in adults

Generic Name: Cal + Vit D

Strength:600mg;1000IU

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:White tablet, film coated

Segment :B

Innovator:Ostevit D + Calcium®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients:
calcium carbonate 1.5g
Equivalent: calcium 600mg
colecalciferol 1000 IU

More info
X
Indication:

Temporary relief from the following cold & flu symptoms: nasal congestion, sinus pain, runny nose, headache, body aches & pains. Reduces fever. The night tablets also provide relief from sneezing and itchy or watery eyes, and assist rest by providing relief from these symptoms.

Generic Name: Fludol Day & Night

Strength:500mg;30mg;2mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 24

Tablet Description:White, round tablet with break-line

Segment :B

Innovator:Codral Original Day & Night®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: paracetamol 500.4mg
pseudoephedrine hydrochloride 30mg

More info
X
Indication:

Treatment of Vaginal Thrush

Generic Name: Femzole

Strength:150mg

Dosage:Cap

Shelflife Months: 36

Pack Size: 1

Tablet Description:Blue /blue hard gelatin capsules

Segment :B

Innovator:Difllucan One®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: fluconazole 150mg

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

ALLERGIES: Treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. ,UPPER RESPIRATORY TRACT: Relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis.,NAUSEA AND VOMITING: Antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. ,SEDATION: For short term use on the advice of a doctor or pharmacist.

Generic Name: Promezine

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 50

Tablet Description:Round, pale blue to blue, film coated tablet, plain on both sides.

Segment :B

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: promethazine hydrochloride 10mg

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Rheumatoid Arthritis,Yuflyma is indicated for reducing signs and symptoms, as well as inhibiting the progression of structural damage in adult patients with moderate to severely active rheumatoid arthritis. This includes the treatment of patients with recently diagnosed moderate to severely active disease who have not received methotrexate.
Yuflyma can be used alone or in combination with methotrexate.,Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Yuflyma in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response to one or more disease modifying anti-rheumatic drugs (DMARDs). Yuflyma can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.,Enthesitis-Related Arthritis,Yuflyma is indicated for the treatment of enthesitis-related arthritis in children, who have had an inadequate response to, or who are intolerant to, conventional therapy.,Psoriatic Arthritis,Yuflyma is indicated for the treatment of signs and symptoms, as well as inhibiting the progression of structural damage, of moderate to severely active psoriatic arthritis in adult patients where response to previous DMARDs has been inadequate.,Ankylosing Spondylitis,Yuflyma is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.
Crohn's Disease in Adults and Children (6 years and older),Yuflyma is indicated for the treatment of moderate to severe Crohn's disease, to reduce the signs and symptoms of the disease and to induce and maintain clinical remission in patients;,· who have had an inadequate response to conventional therapies or,,· who have lost response to or are intolerant to infliximab,Ulcerative colitis,Yuflyma is indicated for the treatment of moderate to severe ulcerative colitis in adult patients who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies. Patients should show a clinical response within 8 weeks of treatment to continue treatment beyond that time. (see 5.1 PHARMACODYNAMIC PROPERTIES - CLINICAL TRIALS).,Psoriasis in Adults and Children,Yuflyma is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.,Yuflyma is indicated for the treatment of severe chronic plaque psoriasis in children and adolescent patients from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapy.,Hidradenitis Suppurativa in Adults and Adolescents (from 12 years of age),Yuflyma is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in patients with an inadequate response to conventional systemic hidradenitis suppurativa therapy.,Uveitis,Yuflyma is indicated for the treatment of non-infectious intermediate, posterior and pan-uveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid sparing, or in whom corticosteroid treatment is inappropriate.

Generic Name: Adalimumab

Strength:40mg/0.4ml

Dosage:

Shelflife Months: 36

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:Yes

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: Adalimumab 40mg

More info
X
Indication:

Pharmacor Finasteride 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. Pharmacor Finasteride 1 is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Generic Name: Finasteride

Strength:1mg

Dosage:Tabs

Shelflife Months: 48

Pack Size: 28

Tablet Description:Reddish brown, 7 mm, round, biconvex, film-coated tablet, marked 'F1' on one side and plain on the other

Segment :A

Innovator:Propecia®

PBSListed:No

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: finasteride 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02569-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02570-1

More info
X
Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

More info
X
Indication:

Primary HypercholesterolaemiaPHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients:,· not appropriately controlled with rosuvastatin or ezetimibe alone; or,· already treated with rosuvastatin and ezetimibe,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).

Generic Name: Ezetimibe; Rosuvastatin

Strength:

Dosage:

Shelflife Months:

Pack Size:

Tablet Description:

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-01230-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-01229-1

More info
X
Indication:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. PHARMACOR METFORMIN XR 500, PHARMACOR METFORMIN XR 750 or PHARMACOR METFORMIN XR 1000 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Generic Name: Metformin hydrochloride

Strength:500mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 120

Tablet Description:White to off white, oval shaped, biconvex tablets with MX debossed on one side and 500 on other side

Segment :A

Innovator:Diabex XR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: metformin hydrochloride 500mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02436-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02437-1

More info
X
Indication:


Cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: Acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis.
Acute exacerbations of chronic bronchitis, or acute bronchitis.
Skin and skin structure infections for example, furunculosis, pyoderma and impetigo.
Acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.

Generic Name: Cefuroxime axetil

Strength:250mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 14

Tablet Description:Blue color capsule shaped biconvex film coated tablets with '204' debossed on one side and plain on the other side

Segment :A

Innovator:Pharmacor Cefuroxime®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: cefuroxime axetil 300.715mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-01527-1&d=20241003172310101

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-01526-1&d=20241003172310101

More info
X
Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

More info
X
Indication:

Relief of pain in acute gout. Colchicine should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient. Colchicine is not an analgesic and does not provide relief from other types of pain.

Generic Name: Colchicine

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 31

Pack Size: 30

Tablet Description:Round, off white coloured biconvex, uncoated tablets embossed “C5” on one upper side and plain on the bottom face

Segment :A

Innovator:Colgout®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: colchicine 500 microgram

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01410-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01413-1

More info
X
Indication:

Pharmacor Sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months:

Pack Size:

Tablet Description:Pink coloured, capsule shaped, biconvex film coated tablet plain on both sides

Segment :A

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: sumatriptan succinate 69.99mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-01148-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01298-1

X
Indication:

Emergency contraception within 72 hours of unprotected intercourse.

Generic Name: Postinor

Strength:1.5mg

Dosage:Tab

Shelflife Months: 36

Pack Size: 1

Tablet Description:Almost white, flat, rimmed tablet with an impressed mark of "GOO" on one side

Segment :A

Innovator:Postinor®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: levonorgestrel 1.5mg

More info
X
Indication:

PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Generic Name: Rasagiline

Strength:1mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side

Segment :A

Innovator:Azilect®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: rasagiline mesilate 1.56mg
Equivalent: rasagiline 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-02457-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-CMI-02459-1

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.15mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.15mg

X
Indication:

For the prevention of travel sickness

Generic Name: Travel-Ease

Strength:0.3mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 24

Tablet Description:Pink colored, biplanar, round shaped, beveled edges uncoated tablets with break line on one side and plain on other side.

Segment :A

Innovator:

PBSListed:No

RPBSlisted:

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hyoscine hydrobromide 0.3mg

More info
X
Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength:110mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator:Pradaxa ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02037-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02036-1

More info
X
Indication:

The symptomatic short term treatment of seasonal allergic conjunctivitis in adults and children 3 years or older.

Generic Name: Ketotifen

Strength:5mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:A clear, colorless solution

Segment :A

Innovator:Zaditen®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ketotifen fumarate 345 microgram/ml
Equivalent: ketotifen 250 microgram/ml

More info
X
Indication:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. PHARMACOR METFORMIN XR 500, PHARMACOR METFORMIN XR 750 or PHARMACOR METFORMIN XR 1000 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Generic Name: Metformin hydrochloride

Strength:500mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 120

Tablet Description:White to off white, oval shaped, biconvex tablets with MX debossed on one side and 500 on other side

Segment :A

Innovator:Diabex XR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: metformin hydrochloride 500mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02436-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02437-1

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Hypertension
PHARMACOR AMLODIPINE is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of PHARMACOR AMLODIPINE, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.
Angina
PHARMACOR AMLODIPINE is indicated for the first line treatment of chronic stable angina. PHARMACOR AMLODIPINE may be used alone, as monotherapy or in combination with other antianginal drugs.

Generic Name: Amlodipine

Strength:5mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off-white, octagonal, flat faced, bevelled edged scored tablet debossed with "210" and "5" on one side and plain on other side

Segment :B

Innovator:Norvasc ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: amlodipine besilate 6.93mg
Equivalent: amlodipine 5mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-02327-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-02330-1

More info
X
Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

More info
X
Indication:

Atorvastatin is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia.
Prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated.
Atorvastatin is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic CHD (see section 5.1, Pharmacodynamic properties, Prevention of Cardiovascular Disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke.
These effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Generic Name: Atorvastatin

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White elliptical shaped, film coated tablets, debossed with "10" on one side and "ATS" on other side

Segment :B

Innovator:Lipitor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: atorvastatin calcium trihydrate 10.845mg
Equivalent: atorvastatin 10mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02356-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02369-1

More info
X
Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

More info
X
Indication:

Relief of pain in acute gout. Colchicine should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient. Colchicine is not an analgesic and does not provide relief from other types of pain.

Generic Name: Colchicine

Strength:0.5mg

Dosage:Tabs

Shelflife Months: 31

Pack Size: 30

Tablet Description:Round, off white coloured biconvex, uncoated tablets embossed “C5” on one upper side and plain on the bottom face

Segment :A

Innovator:Colgout®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: colchicine 500 microgram

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01410-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01413-1

More info
X
Indication:


Generic Name: Cephalexin

Strength:500mg

Dosage:Caps

Shelflife Months: 36

Pack Size: 20

Tablet Description:

Segment :B

Innovator:Keflex®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:

Active Ingredients:

More info
X
Indication:

1. For symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion: i) Duodenal ulcer; ii) Gastric ulcer; iii) Gastro-oesophageal reflux disease (GORD): Symptomatic GORD. The treatment of heartburn and other symptoms associated with GORD; Reflux oesophagitis; iv) Gastrointestinal lesions refractory H2 blockers; v) Zollinger-Ellison Syndrome. Patients whose gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. Maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. Prevention of gastroduodenal lesions and dyspeptic symptoms associated with non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in increased risk patients with a need for continuous non-selective NSAID treatment.

Generic Name: Pantoprazole

Strength:40mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:Yellow to pale yellow coloured oval, biconvex enteric coated tablets plain on both sides.

Segment :C

Innovator:Somac®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: pantoprazole sodium sesquihydrate 45.4mg
Equivalent: pantoprazole 40mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-01421-3

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-CMI-01268-1

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

DULOXETINE is indicated for the treatment of major depressive disorder (MDD).,DULOXETINE is indicated for the treatment of diabetic peripheral neuropathic pain (DPNP).,DULOXETINE is indicated for the treatment of generalised anxiety disorder (GAD)

Generic Name: Duloxetine

Strength:30mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 28

Tablet Description:Opaque blue colour cap and opaque white colour body, imprinted “Dulox” on cap with white ink and “30 mg” on body with black ink

Segment :B

Innovator:Cymbalta®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: duloxetine hydrochloride 33.66mg

More info
X
Indication:


NEUROCCORD (pregabalin) is indicated for the treatment of neuropathic pain in adults.,NEUROCCORD (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generic Name: Pregabalin

Strength:25mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 56

Tablet Description:White opaque/White opaque, size 4 hard gelatin capsules imprinted with PG on cap and 25 on body containing white to off white powder

Segment :B

Innovator:Lyrica®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: pregabalin 25mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02303-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-02135-1 https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02304-1

More info
X
Indication:


GABACOR is indicated for the treatment of,· Partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,· Neuropathic pain.

Generic Name: Gabapentin

Strength:100mg

Dosage:Caps

Shelflife Months: 36

Pack Size: 100

Tablet Description:White hard gelatin capsule imprinted "216" on body with blue ink

Segment :B

Innovator:Neurontin®

PBSListed:Yes

RPBSlisted:Yes

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: gabapentin 100mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01373-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01374-1

More info
X
Indication:

Olmesartan medoxomil is indicated for the treatment of hypertension.

Generic Name: Olmesartan

Strength:20mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off white coloured, round shape film coated tablets debossed with OLM on one side & 20 on other side

Segment :B

Innovator:Olmetec®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: olmesartan medoxomil 20mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2016-PI-01332-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2016-CMI-01331-1

More info
X
Indication:

Telmisartan is indicated for:,Treatment of hypertension ,Prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

Generic Name: Telmisartan

Strength:40mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description:White to off white oblong shaped biconvex, uncoated tablets debossed with TEL on one side and 40 on other side

Segment :B

Innovator:Micardis ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: telmisartan 40mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01879-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-CMI-01881-1

More info
X
Indication:

PHARMACOR ROSUVASTATIN should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,Prevention of Cardiovascular Events
PHARMACOR ROSUVASTATIN is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking, or a family history of premature coronary heart disease). PHARMACOR ROSUVASTATIN is indicated to:,· Reduce the risk of nonfatal myocardial infarction
· Reduce the risk of nonfatal stroke
· Reduce the risk of coronary artery revascularisation procedures.,In patients with hypercholesterolaemia
PHARMACOR ROSUVASTATIN is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,Prior to initiating therapy with PHARMACOR ROSUVASTATIN, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Generic Name: Rosuvastatin calcium

Strength:5mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:Yellow, round, biconvex, film-coated tablet, debossed 5 on one side and R on other side

Segment :C

Innovator:Crestor®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: rosuvastatin calcium 5.21mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02337-2

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02338-2

More info
X
Indication:

For prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. ,Acute Coronary Syndrome: Clopidogrel Tablets is indicated in combination with aspirin for patients with: ,- Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel Tablets is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularization (surgical or PCI, with or without stent); ,- ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Generic Name: Clopidogrel

Strength:75mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description:Pink coloured, round, biconvex, film coated tablets, debossed with 'Cl' on one side and plain on other side

Segment :B

Innovator:Plavix®

PBSListed:Yes

RPBSlisted:Yes

Schedule:S4

Storage Conditions:
Store below 25 degrees Celsius

Active Ingredients: clopidogrel hydrogen sulfate 97.875mg
Equivalent: clopidogrel 75mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01232-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01233-1

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
More info
X
Indication:

Maintain/support bone health
Aids/assists healthy bone development/growth/building
Maintain/support bone mass/density/integrity
Maintain/support bone strength
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate

Generic Name: Cal-Care

Strength:600mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:Tablet, film coated

Segment :B

Innovator:Caltrate®

PBSListed:No

RPBSlisted:Yes

Schedule:UNS

Storage Conditions:

Active Ingredients: calcium carbonate 1.5g

X
Indication:

Adults (≥ 18 Years)
Primary Hypercholesterolaemia,PHARMACOR EZETIMIBE administered alone, or with an HMG-CoA reductase inhibitor
(statin), is indicated as adjunctive therapy to diet in patients with primary (heterozygous
familial and non-familial) hypercholesterolaemia.,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE, administered with a statin, is indicated for patients with HoFH.
Patients may also receive adjunctive treatments (e.g., LDL apheresis).,Homozygous Sitosterolaemia (Phytosterolaemia),PHARMACOR EZETIMIBE is indicated for the reduction of elevated sitosterol and
campesterol levels in patients with homozygous familial sitosterolaemia.,Prevention of Cardiovascular Disease,PHARMACOR EZETIMIBE, is indicated for administration in combination with the
maximum tolerated dose of a statin with proven cardiovascular benefit in patients with
coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) in need of
additional lowering of LDL-C in the expectation of a modest further reduction in the risk of
cardiovascular events following at least one year of therapy (see Section 5.1 Pharmacodynamic Properties, Clinical trials).,Children and Adolescents 10-17 Years
(pubertal status: boys Tanner Stage II and above and girls who are at least one year postmenarche),Heterozygous Familial Hypercholesterolaemia (HeFH),PHARMACOR EZETIMIBE co-administered with simvastatin (doses up to 40 mg) is
indicated as an adjunctive therapy to diet in adolescent patients (10-17 years old) with
heterozygous familial hypercholesterolaemia where use of a combination product is
appropriate:,? Patients not appropriately controlled with a statin or ezetimibe alone
? Patients already treated with a statin and ezetimibe,Homozygous Familial Hypercholesterolaemia (HoFH),PHARMACOR EZETIMIBE co-administered with simvastatin (doses up to 40 mg) is
indicated in adolescent patients (10-17 years old) with HoFH. Patients may also receive
adjunctive treatments (e.g. LDL apheresis)

Generic Name: Ezetimibe

Strength:10mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description:White to off white capsule shaped, flat faced, beveled edge tablets, debossed with A25 on one side and plain on other side

Segment :A

Innovator:Ezetrol®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ezetimibe 10mg

More info
X
Indication:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. PHARMACOR METFORMIN XR 500, PHARMACOR METFORMIN XR 750 or PHARMACOR METFORMIN XR 1000 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Generic Name: Metformin hydrochloride

Strength:500mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 120

Tablet Description:White to off white, oval shaped, biconvex tablets with MX debossed on one side and 500 on other side

Segment :A

Innovator:Diabex XR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: metformin hydrochloride 500mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02436-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-02437-1

More info
X
Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength:30mg

Dosage:MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description:White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator:Glyade MR®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-01570-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-CMI-01869-1

More info
X
Indication:

PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.

Generic Name: Rasagiline

Strength:1mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side

Segment :A

Innovator:Azilect®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: rasagiline mesilate 1.56mg
Equivalent: rasagiline 1mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-PI-02457-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2018-CMI-02459-1

More info
X
Indication:

Dabigatran is indicated for Prevention of venous thromboembolic events in adult patients who have undergone major orthopaedic surgery of the lower limb (elective total hip or knee replacement). Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke. Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults.

Generic Name: Dabigatran

Strength:110mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 60

Tablet Description:White to pale yellow pellets in HPMC capsule size "0EL" Lt blue opq body & Lt cream opq cap imprinted "150" on body & "DAB" on cap in black ink

Segment :A

Innovator:Pradaxa ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: dabigatran etexilate mesilate 172.95mg
Equivalent: dabigatran etexilate 150mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-PI-02037-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2022-CMI-02036-1

X
Indication:

Helps enhance/promote bone health
Aids/assists healthy bone development/growth/building
A diet deficient in calcium can lead to osteoporosis in later life. Calcium may help prevent osteoporosis when dietary intake is inadequate Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life
Helps reduce occurrence of muscle cramp
Maintain/support muscle health during the day in adults

Generic Name: Cal + Vit D

Strength:600mg;1000IU

Dosage:Tabs

Shelflife Months: 24

Pack Size: 120

Tablet Description:White tablet, film coated

Segment :B

Innovator:Ostevit D + Calcium®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients:
calcium carbonate 1.5g
Equivalent: calcium 600mg
colecalciferol 1000 IU

X
Indication:

PHARMACOR VARENICLINE is indicated as an aid to smoking cessation in adults over the age of 18 years.

Generic Name: Varenicline

Strength:1mg

Dosage:Tabs

Shelflife Months: 18

Pack Size: 56

Tablet Description:Light blue, capsular biconvex, film coated tablets, debossed with VC on one side and 1 on other side.

Segment :A

Innovator:Myfortic ®

PBSListed:Yes

RPBSlisted:

Schedule:S5

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: varenicline tartrate 1.71mg
Equivalent: varenicline 1 mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-PI-02127-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-02125-1

More info
X
Indication:


NEUROCCORD (pregabalin) is indicated for the treatment of neuropathic pain in adults.,NEUROCCORD (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generic Name: Pregabalin

Strength:25mg

Dosage:Caps

Shelflife Months: 24

Pack Size: 500

Tablet Description:White opaque/White opaque, size 4 hard gelatin capsules imprinted with PG on cap and 25 on body containing white to off white powder

Segment :B

Innovator:Neurccord®

PBSListed:No

RPBSlisted:No

Schedule:S4

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: pregabalin 25mg

PI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-PI-02303-1

CMI URL:https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2023-CMI-02135-1 https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2017-CMI-02304-1

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

Faecal softener and stimulant laxative

Generic Name: ColoxEase

Strength:50mg/8mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 200

Tablet Description:Dark brown coloured, circular, biconvex, film coaled tablets, plain on both sides

Segment :B

Innovator:Coloxyl with Senna®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: docusate sodium 50mg sennosides 10mg

More info
X
Indication:

Aids/assists healthy bone development/growth/building
Maintain/support bone strength
Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life Maintain/support healthy muscle contraction function
Aid/assist muscle development

Generic Name: Osteo D

Strength:1000IU

Dosage:Caps

Shelflife Months: 24

Pack Size: 250

Tablet Description:Capsule, soft

Segment :B

Innovator:Ostelin®

PBSListed:No

RPBSlisted:No

Schedule:UNS

Storage Conditions:

Active Ingredients: colecalciferol 1000 IU

Image
Product Name
Wholesaler
Strength/Pack Size
Product Info
X
Indication:

Emergency contraception within 72 hours of unprotected intercourse.

Generic Name: Postinor

Strength:1.5mg

Dosage:Tab

Shelflife Months: 36

Pack Size: 1

Tablet Description:Almost white, flat, rimmed tablet with an impressed mark of "GOO" on one side

Segment :A

Innovator:Postinor®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: levonorgestrel 1.5mg

More info
X
Indication:

Provides relief from nasal congestion due to colds, influenza, allergies and sinusitis

Generic Name: Decongestant Nasal

Strength:500mcg/mL

Dosage:Spray

Shelflife Months: 30

Pack Size: 1

Tablet Description:A clear colourless liquid

Segment :B

Innovator:Drixine®

PBSListed:No

RPBSlisted:Yes

Schedule:S2

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: oxymetazoline hydrochloride 0.5 mg/ml

More info
X
Indication:

Temporary relief of acute (short term) pain and / or inflammation associated with:,headache, migraine headache, tension headache, sinus pain, toothache, dental,procedures, backache, muscular aches and pains, period pain, sore throat, tennis,elbow, rheumatic pain and arthritis, and the aches and pains associated with colds and flu.

Generic Name: Fenmol

Strength:500mg;200mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 12

Tablet Description:White to off white coloured, capsule shaped, biconvex, film coated

Segment :B

Innovator:Nuromol ®

PBSListed:No

RPBSlisted:No

Schedule:S2

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: ibuprofen 200mg & paracetamol 500mg

More info
X
Indication:

Temporary relief from the following cold & flu symptoms: nasal congestion, sinus pain, runny nose, headache, body aches & pains. Reduces fever. The night tablets also provide relief from sneezing and itchy or watery eyes, and assist rest by providing relief from these symptoms.

Generic Name: Fludol Day & Night

Strength:500mg;30mg;2mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 24

Tablet Description:White, round tablet with break-line

Segment :B

Innovator:Codral Original Day & Night®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: paracetamol 500.4mg
pseudoephedrine hydrochloride 30mg

More info
X
Indication:

Treatment of Vaginal Thrush

Generic Name: Femzole

Strength:150mg

Dosage:Cap

Shelflife Months: 36

Pack Size: 1

Tablet Description:Blue /blue hard gelatin capsules

Segment :B

Innovator:Difllucan One®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: fluconazole 150mg

More info
X
Indication:


Generic Name: Sumatriptan

Strength:50mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 4

Tablet Description:

Segment :B

Innovator:Imigran ®

PBSListed:Yes

RPBSlisted:No

Schedule:S4

Storage Conditions:

Active Ingredients:

X
Indication:

Topical corticosteroid therapy for the temporary relief of symptoms of non-infected inflammatory conditions of the skin [e.g. minor skin irritations, itching and rashes due to eczema, dermatitis, contact dermatitis (such as rashes due to soap, detergent, cosmetics and jewellery), insect bites, itching of anal and genital areas, and sunburn]

Generic Name: Hydrocortic Clotrimazole

Strength:1%;1%

Dosage:Tube

Shelflife Months: 24

Pack Size: 1

Tablet Description:White soft cream

Segment :A

Innovator:Hydrozole®

PBSListed:

RPBSlisted:

Schedule:

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: hydrocortisone acetate 10mg/g

More info
X
Indication:

ALLERGIES: Treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. ,UPPER RESPIRATORY TRACT: Relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis.,NAUSEA AND VOMITING: Antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. ,SEDATION: For short term use on the advice of a doctor or pharmacist.

Generic Name: Promezine

Strength:10mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 50

Tablet Description:Round, pale blue to blue, film coated tablet, plain on both sides.

Segment :B

Innovator:

PBSListed:

RPBSlisted:

Schedule:S3

Storage Conditions:Store below 30 degrees Celsius

Active Ingredients: promethazine hydrochloride 10mg

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:

Effective relief from persistent pain for up to 8 hours. Effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. Provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. Reduces fever.

Generic Name: Paracetamol

Strength:665mg

Dosage:MR Tabs

Shelflife Months: 48

Pack Size: 192

Tablet Description:White to off white beveled shaped, biconvex, film coated tablets plain on both sides

Segment :O

Innovator:Osteomol 665 Paracetamol ®

PBSListed:Yes

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: paracetamol 665mg

More info
X
Indication:


Generic Name: Nystatin

Strength:24mL

Dosage:Liquid

Shelflife Months: 24

Pack Size: 1

Tablet Description:Yellow coloured Homogenous Suspension

Segment :B

Innovator:Nilstat®

PBSListed:No

RPBSlisted:Yes

Schedule:S3

Storage Conditions:

Active Ingredients:

More info
X
Indication:


Generic Name: Ibuprofen

Strength:400mg

Dosage:tabs

Shelflife Months: 36

Pack Size: 24

Tablet Description:

Segment :B

Innovator:Nuforen Double Strength ®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:

Active Ingredients:

More info
X
Indication:

<a href="https://www.tga.gov.au/resources/cancellations-by-sponsors/trust-restamine-doxylamine-succinate-25mg-tablet-blister-pack-cancelled-under-section-301c-act">https://www.tga.gov.au/resources/cancellations-by-sponsors/trust-restamine-doxylamine-succinate-25mg-tablet-blister-pack-cancelled-under-section-301c-act</a>

Generic Name: Restamine

Strength:25mg

Dosage:Tabs

Shelflife Months: 24

Pack Size: 20

Tablet Description:White to off white circular biconvex uncoated tablets, breakline on one side and plain on the other

Segment :B

Innovator:Restavit ®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:

Active Ingredients:

More info
X
Indication:

TRUST DIFENAC RAPID diclofenac potassium 25 mg tablets are used in short-term treatment (up to one week) for the relief of acute pain states in which there is an inflammatory component. Treatment of acute migraine attacks (with or without aura). Symptomatic treatment of primary dysmenorrhoea.

Generic Name: Difenac Rapid

Strength:25mg

Dosage:Tabs

Shelflife Months: 36

Pack Size: 30

Tablet Description:Pink coloured, circular, biconvex, film coated tablets, plain on both sides

Segment :A

Innovator:Voltaren Rapid®

PBSListed:No

RPBSlisted:No

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: diclofenac potassium 25mg

Warnings:Protect from Heat

More info
X
Indication:

A broad spectrum antifungal for the effective treatment of vaginal candidiasis (commonly referred to as thrush) and the relief of the associated symptoms such as itching, burning and vaginal discharge.

Generic Name: Clotrimazole

Strength:0.02

Dosage:Tube

Shelflife Months: 36

Pack Size: 1

Tablet Description:White, smooth semi-solid cream

Segment :B

Innovator:Canesten 3 Day Cream ®

PBSListed:No

RPBSlisted:Yes

Schedule:S3

Storage Conditions:Store below 25 degrees Celsius

Active Ingredients: clotrimazole 10mg/g